Macular degeneration trials in South Korea

In South Korea 9 Also abroad 220

9 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Where
Daegu, Gyeonggi-do, Seoul
Age
50 years and over
People
250 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06847542 · EU 2024-516924-32-00
No phaseTaking people
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
Where
Seoul
Age
50 years and over
People
1,000 worldwide
Run by
University of Wisconsin, Madison
See details and how to joinNCT06924021
Phase 3Active, not recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Where
Daegu, Seogu, Seongnam-si, Seoul
Age
50 years and over
People
480 worldwide
Run by
4D Molecular Therapeutics
See details and how to joinNCT07064759
Phase 4Taking people
Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration
Where
Seongnam, Seoul
Age
50 years and over
People
64
Run by
Junyeop Lee
See details and how to joinNCT07367282
No phaseNot yet taking people in South Korea
Evaluation of an Electric Stimulator for Medical Use by Personal (LRTPM1) for Visual Function in Early to Intermediate Dry Age-Related Macular Degeneration
Where
Ansan, Seoul
Age
50 years and over
People
40
Run by
Nu Eyne Co., Ltd.
See details and how to joinNCT07700147
Phase 3Taking people
Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy
Where
Seoul
Age
50 years and over
People
266
Run by
SANGMYUNG innovation
See details and how to joinNCT07695207
Phase 3Taking people
Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy
Where
Daegu
Age
50 years and over
People
50
Run by
Yeungnam University College of Medicine
See details and how to joinNCT07461441
Phase 4Not yet taking people in South Korea
Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization
Where
Seoul
Age
50 years and over
People
30
Run by
Kim's Eye Hospital
See details and how to joinNCT07187804
No phaseTaking people
Analysis of Biomarkers From Patients With Chorioretinal Diseases
Where
Daegu
Age
20 years to 80 years
People
100
Run by
Kyungpook National University Hospital
See details and how to joinNCT02026843